Apple's Next Project: Tackling Heart Disease
Apple Inc. (NASDAQ: AAPL) is launching the Apple Heart Study, a program that will explore if using the Apple Watch to monitor heart rhythm can benefit patients, healthcare providers, and insurers. The study could save lives and drive demand for its products, so let's take a closer look.
Wearables represent a massive opportunity to improve patient health and, as a result, Apple's investing in hardware and software that can provide life-saving insight for people with an undiagnosed or chronic disease.
Source: Fool.com
Apple Inc. Aktie
Leichtes Buy-Übergewicht bei der Apple Inc. Aktie mit 152 zu 17 Einschätzungen.
Mit einem Kursziel von 227 € für Apple Inc. ist ein leichter Anstieg gegenüber dem aktuellen Kurs von 200.8 € zu erwarten.